New York City-based NYU Langone Health has selected Alec Kimmelman, MD, PhD, as the next CEO and dean of NYU Grossman School of Medicine, effective Sept. 1.
Dr. Kimmelman, a researcher and radiation oncologist, joined the health system in 2016 and most recently served as director of the Laura and Isaac Perlmutter Cancer Center.
In his new role, he will succeed Robert Grossman, MD, who is retiring.
“We are excited to name Dr. Kimmelman to this position, given his extraordinary talent, leadership experience and strong character. He is the right choice to build on Bob’s legacy and lead our institution into its next phase of innovation and impact,” Kenneth Langone, chair of the NYU Langone board of trustees and co-chair of the search committee, said in a March 31 system news release. “Finding Bob’s successor was a formidable task, given his countless contributions to our institution, but we found such a leader in Dr. Kimmelman, who has demonstrated tremendous leadership throughout his career.”
Last summer, Dr. Grossman shared plans to retire after nearly two decades with the health system. Upon his retirement, he will become executive vice president to the board, according to the release. Mr. Langone will also retire from his role as board chair around that time but will remain a board member. Fiona Druckenmiller will become the new board chair.
NYU Langone Health is a $14.2 billion organization that operates seven inpatient locations, more than 320 outpatient sites, two tuition-free medical schools and a robust research enterprise.
